Consistently, while activating GLP1NTS cells decreased food intake, LepRbNTS cells elicited larger and more durable effects
Potential Side Effects of GLP-1 That May Affect IBS Gastrointestinal side effects are the most commonly reported adverse reactions with GLP-1 receptor agonists, occurring in a significant proportion of patients, particularly during treatment initiation and dose escalation
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Thiazolidinedione use and bone loss in older diabetic adults
No needles, no mixing, no refrigeration required in most cases
Managing GI discomfort during dose escalation supports medication adherence, which is the critical intermediate outcome